Driving Global Access to Life-Saving Therapies
From D.C. policy to Ori Biotech CEO, Jason Foster shares on Favorable Environments strategies for assembling problem-solving teams in cell/gene therapy R&D, revolutionizing scalable manufacturing for broader access. Echoing his pharma scaling expertise, he envisions academia-industry alliances transforming outcomes in a $8.94B 2025 market.